Clinical Trial Update: Study of TGM-312-SC01 in Healthy Participants and Adults With MASH [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of TGM-312-SC01 in healthy participants and adults with metabolic dysfunction-associated steatohepatitis (MASH) is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• TGM-312-SC01

Snippet

Sponsor: Tangram Therapeutics Plc | Conditions: Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis | Phase 1, Phase 2 | Status: RECRUITING